AbelZeta Pharma

$22.0M revenue • 120 employees • United States

Last Updated May 10, 2025

Company Overview

Company Name

AbelZeta Pharma

Address

United States

Approx. Annual Revenue

$22.0M

Employees

120

Established

2023

Locations

2

About AbelZeta Pharma

AbelZeta Pharma is a global, clinical-stage biopharmaceutical company focused on developing innovative T cell-based therapies to treat cancer, inflammation, and immunological diseases. Headquartered in the United States, the company leverages its R&D capabilities to discover and advance novel therapeutic solutions that empower the immune system to fight these challenging conditions.

Business Profile

Read from the AbelZeta Pharma website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current copyright 2026; Clear navigation and contact
Footer copyright year
2026

Recent changes

What changed on the AbelZeta Pharma website and Google listing, as detected by Coldlytics on each visit.

  1. Estimated revenue band moved from $5M-10M to $10M-25M

  2. Estimated headcount moved from 21-50 to 101-250 employees

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

AbelZeta Pharma locations

2 Google Business Profile listings.

LocationGoogle categoryReviewsStatus
AbelZeta Pharmaprimary———
9605 Medical Center Dr #100, Rockville, MD——Claimed

Biotech & Life Sciences Companies near DC

Browse all Biotech & Life Sciences companies →

Frequently Asked Questions about AbelZeta Pharma

Categories

Technologies Used

Key Decision Makers

Shari Pearson Associate Director of Clinical Operations and Strategy
LinkedIn